trending Market Intelligence /marketintelligence/en/news-insights/trending/4UWW73pCcq-DSGwIFVSMpA2 content esgSubNav
In This List

Draper, Pfizer collaborate on microphysiological systems technology

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Draper, Pfizer collaborate on microphysiological systems technology

Draper, an independent, not-for-profit engineering research and development company, entered into a three-year collaboration agreement with Pfizer Inc. to create variations of Draper's microphysiological systems technology.

The partnership aims to advance preclinical safety testing and develop effective disease models.

In the collaboration, Draper will create three unique models of microphysiological systems for liver, vascular and gastrointestinal organs.

Draper's microphysiological systems technology aims to recapitulate human tissues, enabling researchers to measure tissue function more accurately and more quickly compared to traditional preclinical models.